16/04/2024
Audrain R et al., Brain Communications, 2023
Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF
Audrain M, Egesipe AL, Tentillier N, Font L, Ratnam M, Mottier L, Clavel M, Le Roux-Bourdieu M, Fenyi A, Ollier R, Chevalier E, Guilhot F, Fuchs A, Piorkowska K, Carlyle B, Arnold SE, Berry JD, Luthi-Carter R, Adolfsson O, Pfeifer A, Kosco-Vilbois M, Seredenina T, Afroz T
27/10/2023
Smith R et al., Nature Communications, 2023
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
Smith R, Capotosti F, Schain M, Ohlsson T, Vokali E, Molette J, Touilloux T, Hliva V, Dimitrakopoulos IK, Puschmann A, Jögi J, Svenningsson P, Andréasson M, Sandiego C, Russell DS, Miranda-Azpiazu P, Halldin C, Stomrud E, Hall S, Bratteby K, Tampio L’Estrade E, Luthi-Carter R, Pfeifer A, Kosco-Vilbois M, Hansson O
29/08/2023
Ollier R et al., mAbs, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework
Ollier R, Fuchs A, Gauye F, Piorkowska K, Menant S, Ratnam M, Montanari P, Guilhot F, Phillipe D, Audrain M, Egesipe AL, Névoltris D, Seredenina T, Pfeifer A, Kosco-Vilbois M, Afroz T
20/02/2023
Afroz T et al., Neurobiology of Disease, 2023
Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
Afroz T, Chevalier E, Audrain M, Dumayne C, Ziehm T, Moser R, Egesipe AL, Mottier L, Ratnam M, Neumann M, Havas D, Ollier R, Piorkowska K, Chauhan M, Silva AB, Thapa S, Stöhr J, Bavdek A, Eligert V, Adolfsson O, Nelson PT, Porta S, Lee VMY, Pfeifer A, Kosco-Vilbois M, Seredenina T
24/12/2022
Njavro JR et al., Cells, 2023, 12, 79
Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model
Rudan Njavro J, Vukicevic M, Fiorini E, Dinkel L, Müller S.A., Berghofer A, Bordier C, Kozlov S, Halle A, Buschmann K, Capell A, Giudici C, Willem M, Feederle R, Lichtenthaler S.F., Babolin C, Montanari P, Pfeifer A, Kosco-Vilbois M, Tahirovic S
09/05/2022
Rafii M et al., JAMA Neurology, 2022
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial
Rafii MS, Sol O, Mobley WC, Delpretti S, Skotko BG, Burke AD, Sabbagh MN, Yuan SH, Rissman RA, Pulsifer M, Evans C, Carol Evans A, Beth G, Fournier N, Gray JA, Melo dos Santos A, Hliva V, Vukicevic M, Kosco-Vilbois M, Streffer J, Pfeifer A, Feldman HH
04/02/2022
Vukicevic M et al., Brain Communications, 2022
An Amyloid beta (Abeta) vaccine that safely drives immunity to a key pathological species in Alzheimer’s disease: pyroglutamate Abeta
Vukicevic M, Fiorini E, Siegert S, Carpintero R, Rincon M, Lopez-Deber P, Piot N, Ayer M, Rentero I, Babolin C, Bravo-Veyrat S, Giriens V, Morici C, Beuzelin M, Gesbert A, Rivot S, Depretti S, Donati P, Streffer J, Pfeifer A, Kosco-Vilbois MH
15/12/2021
Kroth H et al., Bioorg. Med. Chem., 2021
Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core
Kroth H, Oden F, Serra AM, Molette J, Mueller A, Berndt M, Capotosti F, Gabellieri E, Schmitt-Willich H, Hickman D, Pfeifer A, Dinkelberg L, Stephens A
29/08/2021
Kroth H et al., J. Med. Chem. 2021
PI-2620 lead optimization highlights the importance of off-target assays to develop a pet tracer for the detection of pathological aggregated tau in Alzheimer’s disease and other tauopathies
Kroth H, Oden F, Molette J, Schieferstein H, Gabellieri E, Mueller A, Berndt M, Sreenivasachary N, Serra AM, Capotosti F, Schmitt-Willich H, Hickman D, Pfeifer A, Dinkelborg L, and Stephens A
12/05/2021
Ayalon G et al., Sci. Transl. Med., 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease
Ayalon G, Lee S-H, Adolfsson O, Foo-Atkins C, Atwal JK, Blendstrup M, Booler H, Bravo J, Brendza R, Brunstein F, Chan R, Chandra P, Couch JA, Datwani A, Demeule B, DiCara D, Erickson R, Ernst JA, Foreman O, He D, Hötzel I, Keeley M, Kwok MCM, Lafrance-Vanasse J, Lin H, Lu Y, Luk W, Manser P, Muhs A, Ngu H, Pfeifer A, Pihlgren M, Rao GK, Scearce-Levie K, Schauer SP, Smith WB, Solanoy H, Teng E, Wildsmith KR, Bumbaca Yadav D, Ying Y, Fuji RN, Kerchner GA
15/10/2020
Gabellieri E et al. , Eur. J. Med. Chem., 2020
Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated Tau in Alzheimer's disease and other tauopathies
Gabellieri E, Capotosti F, Molette J, Sreenivasachary N, Mueller A, Berndt M, Schieferstein H, Juergens T, Varisco Y, Oden F, Schmitt-Willich H, Hickman D, Dinkelborg L, Stephens A, Pfeifer A, Kroth H
11/11/2019
Bullich S et al., J. Nucl. Med., 2019
Evaluation of dosimetry, quantitative methods and test-retest variability of 18F-PI-2620 PET for the assessment of Tau deposits in the human brain
Bullich S, Barret O, Constantinescu C, Sandiego C, Mueller A, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A, Madonia J, Seiby JP, Marek K, de Santi, Dinkelborg LM, Berndt M, Tamagnan G, Stephens AW
11/11/2019
Mueller A et al., J. Nucl. Med., 2019
Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study
Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A, Tamagnan G, Seibyl JP, Marek K, de Santi S, Dinkelborg LM, Stephens AW
20/09/2019
Sreenivasachary N et al., Org. Process Res. Dev., 2019
A Short Synthesis of the 2-Bromo-N,9-dimethyl-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]indol-6-amine Building Block
Sreenivasachary N, Kroth H, Benderitter P, Barth W, Pfeifer A, Muhs A
01/07/2019
Kroth H et al., Eur. J. Nucl. Med. Mol. Imaging , 2019
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, Berndt M, Schmitt-Willich H, Darmency V, Gabellieri E, Boudou C, Juergens T, Varisco Y, Vokali E, Hickman DT, Tamagnan G, Pfeifer A, Dinkelborg L, Muhs A, Stephens AW
13/11/2018
Chen H-H et al., Scientific Reports, 2018
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
Hsu-Hsin Chen, Peter Liu, Paul Auger, Seung-Hye Lee, Oskar Adolfsson, Lorianne Rey-Bellet, Julien Lafrance-Vanasse, Brad A. Friedman, Maria Pihlgren, Andreas Muhs, Andrea Pfeifer, James Ernst, Gai Ayalon, Kristin R. Wildsmith, Thomas G. Beach & Marcel P. van der Brug
19/10/2017
Lathuilière A et al., Scientific Reports, 2017
Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects
Aurélien Lathuilière, Pamela Valdés, Stéphanie Papin, Matthias Cacquevel, Catherine Maclachlan, Graham W. Knott, Andreas Muhs, Paolo Paganetti, Bernard L. Schneider
15/03/2017
Sreenivasachary N et al., Bioorganic & Medicinal Chemistry Letters, 2017
Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer’s disease
Nampally Sreenivasachary, Heiko Kroth, Pascal Benderitter, Anne Hamel, Yvan Varisco, David T. Hickman, Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs
20/12/2016
Ultsch M et al., Scientific Reports, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
Mark Ultsch, Bing Li, Till Maurer, Mary Mathieu, Oskar Adolfsson, Andreas Muhs, Andrea Pfeifer, Maria Pihlgren, Travis W. Bainbridge, Mike Reichelt, James A. Ernst, Charles Eigenbrot, Germaine Fuh, Jasvinder K. Atwal, Ryan J. Watts, Weiru Wang
02/11/2016
Theunis C et al., J. Alzheimer. Dis., 2016
Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope
Clara Theunis, Oskar Adolfsson, Natalia Crespo-Biel, Kasia Piorkowska, Maria Pihlgren, David T. Hickman, Valerie Gafner, Peter Borghgraef, Herman Devijver, Andrea Pfeifer, Fred Van Leuven, Andreas Muhs
09/08/2016
Lee S-H et al., Cell Reports, 2016
Antibody-mediated targeting of Tau in vivo does not require effector function and microglial engagement
Seung-Hye Lee, Claire E. Le Pichon, Oskar Adolfsson, Valerie Gafner, Maria Pihlgren, Han Lin,Hilda Solanoy, Robert Brendza, Hai Ngu, Oded Foreman, Ruby Chan,James A. Ernst, Danielle DiCara, Isidro Hotzel, Karpagam Srinivasan, David V. Hansen, Jasvinder Atwal, Yanmei Lu, Daniela Bumbaca, Andrea Pfeifer, Ryan J. Watts, Andreas Muhs, Kimberly Scearce-Levie and Gai Ayalon
15/07/2016
Kroth H et al., Bioorganic & Medicinal Chemistry Letters, 2016
Synthesis and structure–activity relationship of 2,6-disubstituted pyridine derivatives as inhibitors of b-amyloid-42 aggregation
Heiko Kroth, Nampally Sreenivasachary, Anne Hamel, Pascal Benderitter, Yvan Varisco, Valérie Giriens, Paolo Paganetti, Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs
29/03/2016
Belichenko PV et al., PLOS one, 2016
An Anti-Beta-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome
Pavel V. Belichenko, Rime Madani, Lorianne Rey-Bellet, Maria Pihlgren, Ann Becker, Adeline Plassard, Stephanie Vuillermot, Valérie Giriens, Rachel L. Nosheny, Alexander M. Kleschevnikov, Janice S. Valletta, Sara K. S. Bengtsson, Gordon R. Linke, Michael T. Maloney, David T. Hickman, Pedro Reis, Anne Granet, Dorin Mlaki, Maria Pilar Lopez-Deber, Long Do, Nishant Singhal, Eliezer Masliah, Matthew L. Pearn, Andrea Pfeifer, Andreas Muhs, William C. Mobley
13/10/2015
Devraj K et al., JCBFM, 2015
BACE-1 is expressed in the blood - brain barrier endothelium and is upregulated in a murine model of Alzheimer's disease
Kavi Devraj, Slobodan Poznanovic, Christoph Spahn, Gerhard Schwall, Patrick N Harter, Michel Mittelbronn, Katia Antoniello, Paolo Paganetti, Andreas Muhs, Mike Heilemann, Richard A Hawkins, André Schrattenholz, Stefan Liebner
05/11/2014
Mlaki Ndao D et al., BioProtocol, 2014
Binding Affinity Measurement of Antibodies from Crude Hybridoma Samples by SPR
Dorin Mlaki Ndao, David T. Hickman, María Pilar López-Deber, Aurélien Davranche, Andrea Pfeifer, Andreas Muhs
10/09/2014
Lopez Deber MP et al., PLoS One, 2014
Engineering Amyloid-Like Assemblies from Unstructured Peptides via Site-Specific Lipid Conjugation
Maria Pilar Lopez Deber, David T. Hickman, Deepak Nand , Marc Baldus, Andrea Pfeifer, Andreas Muhs
25/07/2014
Froestl W et al., Journal of Alzheimer's disease, 2014
Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors
Froestl W, Muhs A, Pfeifer A
25/03/2014
Froestl W et al., Journal of Alzheimer's disease, 2014
Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes
Froestl W, Muhs A, Pfeifer A
21/10/2013
Papassotiropoulos A et al., PNAS, 2013
Human genome-guided identification of memory-modulating drugs
Papassotiropoulos A, Gerhards C, Heck A, Ackermann S, Aerni A, Schicktanz N, Auschra B, Demougin P, Mumme E, Elbert T, Ertl V, Gschwind L, Hanser E, Huynh KD, Jessen F, Kolassa IT, Milnik A, Paganetti P, Spalek K, Vogler C, Muhs A, Pfeifer A, de Quervain DJ
23/08/2013
Koers E et al., Angewandte Chemie International Edition, 2013
Dynamic nuclear polarization NMR spectroscopy: revealing multiple conformations in lipid-anchored peptide vaccines
Koers E, López-Deber MP, Weingarth M, Nand D, Hickman DT, Mlaki Ndao D, Reis P, Granet A, Pfeifer A, Muhs A, Baldus M
19/08/2013
Theunis C et al., PLoS One, 2013
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
Theunis C, Crespo-Biel N, Gafner V, Pihlgren M, Lopez-Deber P, Reis P, Hickman D, Adolfsson O, Chuard N, Mlaki Ndao D, Borghgraef P, Devijver H, Van Leuven F, Pfeifer A, Muhs A
06/08/2013
Paganetti P et al., J. Alzheimers Dis., 2014
Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis
Paganetti P, Antoniello K, Devraj K, Toni N, Kieran D, Madani R, Pihlgren M, Adolfsson O, Froestl W, Schrattenholz A, Liebner S, Havas D, Windisch M, Cirrito JR, Pfeifer A, Muhs A
06/02/2013
Froestl W et al., Journal of Alzheimer's disease, 2013
Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs.
Froestl W, Muhs A, Pfeifer A
03/01/2013
Pihlgren M et al., Blood, 2013
TLR4 and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T-cell independent isotype switch in mice
Pihlgren M, Silva AB, Madani R, Giriens V, Waeckerle-Men Y, Fettelschloss A, Hickman D, Lopez-Deper MP, Mlaki Ndao D, Vukicevic M, Bucarello AL, Gafner V, Chuard N, Reis P, Piorkowska K, Pfeifer A, Kündig TM, Muhs A, Johansen P
